Table 1. Characteristics of included studies.
First author, year | Country | Study interval | Design | LOE‡ | No. of patients: LRC/ORC | Conversion, N(%) | Matching/Comparable* | Follow-up, mo†:LRC/ORCA |
Akin, 2013 [19] | Turkey | 2008–2011 | Prospective | 3b | 15/15 | 0 | 1,2,3,5,6,8 | 40/35 |
Basillote, 2004 [20] | USA | 2001–2003 | Retrospective | 3b | 13/11. | 2/13(15.4%) | 1,2,3,4,6,7,8 | NA |
Ha, 2010 [21] | Korea | 2003–2008 | Retrospective | 3b | 36/34 | 0 | 1,2,3,6 | 22(3–58)/67(6–128) |
Haber, 2008 [22] | USA | NA | Retrospective | 4 | 50/50 | NA | 1,2,3,6 | NA |
Hemal, 2007 [23] | India | 1999–2005 | Prospective | 3b | 30/35 | 0 | 1,2,3,4,6 | NA |
Huang, 2005 [25] | China | 1994–2004 | Retrospective | 4 | 33/48 | 0 | 1,2,6 | 13(1–21)/24(12–96) |
Huang, 2008 [24] | China | 1994–2007 | Retrospective | 4 | 108/63 | 0 | 1,2,3,4,5,6 | (12–65)/(18–168) |
Jin, 2012 [26] | China | 2007–2012 | Retrospective | 4 | 32/35 | 0 | 1,2,6,7 | (6–76) |
Julien, 2009 [27] | France | 2003–2007 | Prospective | 3b | 38/30 | 2/38(5.3%) | 1,2,3,4,5,6,8 | NA |
Khan, 2012 [28] | UK | 2003–2008 | Prospective | 3b | 58/52 | 0 | 1,2,6,8 | 39.4 |
Porpiglia, 2007 [30] | Italy | 2002–2005 | Prospective | 3b | 20/22 | 1/20(5%) | 1,2,4,6,7,8 | 19.5(3–37)/19.2(3–39) |
Taylor, 2004 [31] | USA | 2002–2003 | Prospective | 3b | 8./8 | 0 | 1,2,3,4,6,8 | NA |
Wang1, 2010 [32] | China | 2006–2008 | Prospective | 3b | 14/24 | NA | 1,2,3,4,6,8 | NA |
Wang2, 2010 [33] | China | 2004–2007 | Retrospective | 4 | 31/39 | 0 | 1,2,3,5,6,8 | 18(1–34)/20(1–36) |
Wu, 2009 [29] | China | 2006–2009 | Retrospective | 3b | 15/23 | 0 | 1,2,6,7,8 | (3–8)/(3–24) |
Zhang, 2010 [34] | China | 2007–2009 | Retrospective | 3b | 35/36 | 2/35(5.7%) | 1,2,4,5,6,8 | 51.4 (1–159) |
LRC = laparoscopic radical cystectomy; ORC = open radical cystectomy; LOE = Level of evidence; NA = data not available.
*Matching/comparable variables: 1 = age, 2 = gender, 3 = BMI, 4 = ASA, 5 = Previous surgery history, 6 = indication, 7 = clinical stage, 8 = diversion type;
Mean±SD or Median(Range);
Based on US Preventive Services Task Force grading system.